Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Myristic Acid.
A long-chain saturated fatty acid that functions as a critical substrate for N-myristoyltransferase, facilitating the lipidation and membrane anchoring of signaling proteins involved in cellular transduction and immune response.
11005
228.37 g/mol
5.3
tetradecanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Myristic Acid across standard consumer modalities.
The low melting point of myristic acid (54.4°C) requires careful temperature control during encapsulation to prevent leakage or softening of the gelatin shell.
High concentrations of myristic acid can interfere with pectin gelation and lead to lipid blooming or an oily surface texture in the final gummy matrix.
The high molecular weight and hydrophobic nature of myristic acid severely limit the maximum payload capacity within the thin-film polymer matrix, often resulting in film brittleness.
Ready to launch a product featuring Myristic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Myristic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Myristic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation